Skip to content

A small step for pharma, a giant leap for Mankind

The Rs 4,326-crore IPO, which was subscribed 15.3 times, was one of the biggest by a domestic drug maker since Gland Pharma came up with a Rs 6,480-crore issue in 2020 and the biggest of 2023, so far

Read More

​ The Rs 4,326-crore IPO, which was subscribed 15.3 times, was one of the biggest by a domestic drug maker since Gland Pharma came up with a Rs 6,480-crore issue in 2020 and the biggest of 2023, so far The Rs 4,326-crore IPO, which was subscribed 15.3 times, was one of the biggest by a domestic drug maker since Gland Pharma came up with a Rs 6,480-crore issue in 2020 and the biggest of 2023, so far  Moneycontrol Latest News Read More  

Leave a Reply

Generated by Feedzy
en_USEnglish
%d bloggers like this: